beta-alanine has been researched along with Gastrointestinal Hemorrhage in 33 studies
Gastrointestinal Hemorrhage: Bleeding in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The comparative safety of dabigatran versus warfarin for treatment of nonvalvular atrial fibrillation in general practice settings has not been established." | 7.81 | Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation. ( Goulding, MR; Graham, DJ; Houstoun, M; Kelman, JA; Levenson, M; MaCurdy, TE; Mott, K; Reichman, ME; Sheu, TC; Southworth, MR; Wernecke, M; Worrall, C; Zhang, R, 2015) |
| "Clinical trial data suggest that dabigatran and warfarin have similar rates of major bleeding but higher rates of gastrointestinal bleeding." | 7.80 | Bleeding rates in Veterans Affairs patients with atrial fibrillation who switch from warfarin to dabigatran. ( Chrischilles, E; Cram, P; Jones, M; Mazur, A; Vaughan Sarrazin, MS, 2014) |
| "In an 89-year-old female with atrial fibrillation dabigatran had been started 11 days before admission, following a transitory ischemic attack." | 7.79 | Ischemic stroke and intestinal bleeding under dabigatran in metabolic myopathy. ( Bastovansky, A; Finsterer, J; Paul, G; Stöllberger, C, 2013) |
| "This case demonstrates the potential of a single dose of dabigatran 150 mg to result in a fatal gastrointestinal hemorrhage." | 7.78 | Fatal gastrointestinal hemorrhage after a single dose of dabigatran. ( Boesen, K; Ito, S; Kernan, L; Shirazi, F, 2012) |
| "The comparative safety of dabigatran versus warfarin for treatment of nonvalvular atrial fibrillation in general practice settings has not been established." | 3.81 | Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation. ( Goulding, MR; Graham, DJ; Houstoun, M; Kelman, JA; Levenson, M; MaCurdy, TE; Mott, K; Reichman, ME; Sheu, TC; Southworth, MR; Wernecke, M; Worrall, C; Zhang, R, 2015) |
| "Incidence rates (events/100 patient years) and propensity score matched Cox proportional hazards models were used to estimate rates of total gastrointestinal bleeds, upper gastrointestinal bleeds, and lower gastrointestinal bleeds for the novel oral anticoagulants compared with warfarin in patients with and without atrial fibrillation." | 3.81 | Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study. ( Abraham, NS; Alexander, GC; Crown, W; Haas, LR; Heien, H; Shah, ND; Singh, S, 2015) |
| "Clinical trial data suggest that dabigatran and warfarin have similar rates of major bleeding but higher rates of gastrointestinal bleeding." | 3.80 | Bleeding rates in Veterans Affairs patients with atrial fibrillation who switch from warfarin to dabigatran. ( Chrischilles, E; Cram, P; Jones, M; Mazur, A; Vaughan Sarrazin, MS, 2014) |
| "Dabigatran is an oral direct thrombin inhibitor that is Food and Drug Administration-approved for prevention of stroke in patients with atrial fibrillation." | 3.79 | Extracorporeal therapy for dabigatran removal in the treatment of acute bleeding: a single center experience. ( Hallows, KR; Henry, BL; Maw, TT; Nolin, TD; Pastor-Soler, NM; Singh, T; Unruh, ML, 2013) |
| "In an 89-year-old female with atrial fibrillation dabigatran had been started 11 days before admission, following a transitory ischemic attack." | 3.79 | Ischemic stroke and intestinal bleeding under dabigatran in metabolic myopathy. ( Bastovansky, A; Finsterer, J; Paul, G; Stöllberger, C, 2013) |
| "A 66-year-old woman treated with dabigatran for atrial fibrillation developed acute renal failure and upper gastrointestinal bleeding." | 3.78 | Dabigatran-induced gastrointestinal bleeding in an elderly patient with moderate renal impairment. ( Kouides, PA; Wychowski, MK, 2012) |
| "This case demonstrates the potential of a single dose of dabigatran 150 mg to result in a fatal gastrointestinal hemorrhage." | 3.78 | Fatal gastrointestinal hemorrhage after a single dose of dabigatran. ( Boesen, K; Ito, S; Kernan, L; Shirazi, F, 2012) |
| "Treatment with a PCC and FFP was administered to an 85-year-old man diagnosed with hemorrhagic shock secondary to bleeding in his upper gastrointestinal tract in an effort to reverse the anticoagulant effects of dabigatran." | 3.78 | Reversal of dabigatran-induced bleeding with a prothrombin complex concentrate and fresh frozen plasma. ( Dumkow, LE; Jennings, DL; Peters, M; Voss, JR, 2012) |
| " She was on dabigatran for atrial fibrillation and aspirin, with intermittent intake of ibuprofen." | 3.78 | Direct thrombin inhibitors: a case indicating benefit from 'plasmapheresis' in toxicity: a call for establishing "guidelines" in overdose and to find an "antidote"! ( Cirra, VR; Kamboj, J; Kamboj, R; Kottalgi, M; Shah, N, 2012) |
| "Seven were admitted for an intracranial hemorrhage (ICH) and four for a gastrointestinal hemorrhage (GIH)." | 1.40 | Clinical experience of life-threatening dabigatran-related bleeding at a large, tertiary care, academic medical center: a case series. ( Ditch, K; Miller, MA; Ross, B; Tran, M, 2014) |
| "227 dabigatran) were identified." | 1.40 | Risk of gastrointestinal bleeding with dabigatran: a head-to-head comparative study with rivaroxaban. ( Husein, H; Samo, S; Sherid, M; Sifuentes, H; Spurr, C; Sridhar, S; Sulaiman, S; Thiruvaiyaru, D; Tupper, R, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 33 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Holm, J | 1 |
| Taskiran, M | 1 |
| Southworth, MR | 2 |
| Reichman, ME | 2 |
| Unger, EF | 1 |
| Desai, J | 1 |
| Kolb, JM | 1 |
| Weitz, JI | 1 |
| Aisenberg, J | 1 |
| Singh, T | 1 |
| Maw, TT | 1 |
| Henry, BL | 1 |
| Pastor-Soler, NM | 1 |
| Unruh, ML | 1 |
| Hallows, KR | 1 |
| Nolin, TD | 1 |
| Diallo, I | 1 |
| Mallaret, C | 1 |
| Jourdan, S | 1 |
| Brardjanian, S | 1 |
| Guisset, M | 1 |
| Coton, T | 1 |
| Baron, TH | 1 |
| Kamath, PS | 1 |
| McBane, RD | 1 |
| Thachil, J | 1 |
| Pike, G | 1 |
| Keighley-Jones, L | 1 |
| Nash, MJ | 1 |
| Bell, S | 1 |
| Nand, J | 1 |
| Dawes, M | 1 |
| Braun, G | 1 |
| Messmann, H | 1 |
| Gunes, F | 1 |
| Asik, M | 1 |
| Temiz, A | 1 |
| Binnetoglu, E | 1 |
| Sen, H | 1 |
| Bilen, Oİ | 1 |
| Akbal, E | 1 |
| Adam, G | 1 |
| Ukinc, K | 1 |
| Ribés-Cruz, JJ | 1 |
| Torregrosa-Maicas, I | 1 |
| Ramos-Tomás, C | 1 |
| Solís-Salguero, MA | 1 |
| Puchades-Montesa, MJ | 1 |
| González-Rico, MA | 1 |
| Juan-García, I | 1 |
| Tomás-Simó, P | 1 |
| Tejedor-Alonso, S | 1 |
| Zambrano-Esteves, P | 1 |
| Miguel-Carrasco, A | 1 |
| Sipahi, I | 1 |
| Celik, S | 1 |
| Tozun, N | 1 |
| Katz, MH | 1 |
| Finsterer, J | 1 |
| Stöllberger, C | 1 |
| Paul, G | 1 |
| Bastovansky, A | 1 |
| Ross, B | 1 |
| Miller, MA | 1 |
| Ditch, K | 1 |
| Tran, M | 1 |
| Konturek, P | 1 |
| Hess, T | 1 |
| Vaughan Sarrazin, MS | 2 |
| Jones, M | 1 |
| Mazur, A | 1 |
| Chrischilles, E | 1 |
| Cram, P | 1 |
| Clemens, A | 1 |
| Strack, A | 1 |
| Noack, H | 1 |
| Konstantinides, S | 1 |
| Brueckmann, M | 1 |
| Lip, GY | 1 |
| Sherid, M | 1 |
| Sifuentes, H | 1 |
| Sulaiman, S | 1 |
| Samo, S | 1 |
| Husein, H | 1 |
| Tupper, R | 1 |
| Thiruvaiyaru, D | 1 |
| Spurr, C | 1 |
| Sridhar, S | 1 |
| Graham, DJ | 1 |
| Wernecke, M | 1 |
| Zhang, R | 1 |
| Levenson, M | 1 |
| Sheu, TC | 1 |
| Mott, K | 1 |
| Goulding, MR | 1 |
| Houstoun, M | 1 |
| MaCurdy, TE | 1 |
| Worrall, C | 1 |
| Kelman, JA | 1 |
| Sengupta, N | 1 |
| Feuerstein, JD | 1 |
| Patwardhan, VR | 1 |
| Tapper, EB | 1 |
| Ketwaroo, GA | 1 |
| Thaker, AM | 1 |
| Leffler, DA | 1 |
| Abraham, NS | 1 |
| Singh, S | 2 |
| Alexander, GC | 2 |
| Heien, H | 1 |
| Haas, LR | 1 |
| Crown, W | 1 |
| Shah, ND | 1 |
| Rose, A | 1 |
| Chang, HY | 1 |
| Zhou, M | 1 |
| Tang, W | 1 |
| Chan, EW | 1 |
| Lau, WC | 1 |
| Leung, WK | 1 |
| Mok, MT | 1 |
| He, Y | 1 |
| Tong, TS | 1 |
| Wong, IC | 1 |
| Phillips, R | 1 |
| Lythgoe, M | 1 |
| Lewis, LS | 1 |
| Koretz, RL | 1 |
| Wychowski, MK | 1 |
| Kouides, PA | 1 |
| Kernan, L | 1 |
| Ito, S | 1 |
| Shirazi, F | 1 |
| Boesen, K | 1 |
| Dumkow, LE | 1 |
| Voss, JR | 1 |
| Peters, M | 1 |
| Jennings, DL | 1 |
| Kamboj, J | 1 |
| Kottalgi, M | 1 |
| Cirra, VR | 1 |
| Shah, N | 1 |
| Kamboj, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy and Safety of Apixaban in Patients With Active Malignancy and Acute Deep Venous Thrombosis.[NCT04462003] | Phase 3 | 100 participants (Anticipated) | Interventional | 2019-07-03 | Recruiting | ||
| Blood Flow Monitoring to Prevent Post-Polypectomy Induced Ulcer Bleeding.[NCT02875353] | 235 participants (Anticipated) | Interventional | 2017-02-15 | Recruiting | |||
| A Monitor System for the Safety of Dabigatran Anticoagulation Treatment in Nonvalvular Atrial Fibrillation[NCT02414035] | 1,496 participants (Actual) | Observational | 2015-03-22 | Completed | |||
| Randomized Evaluation of Decision Support Interventions for Atrial Fibrillation[NCT04357288] | 1,200 participants (Anticipated) | Interventional | 2020-12-16 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for beta-alanine and Gastrointestinal Hemorrhage
| Article | Year |
|---|---|
Gastrointestinal bleeding with the new oral anticoagulants--defining the issues and the management strategies.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; | 2013 |
New anticoagulant and antiplatelet agents: a primer for the gastroenterologist.
Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation Factors; Cholangiopancreatography, E | 2014 |
[Gastrointestinal bleeding in cardiological patients].
Topics: Algorithms; Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation Factors; Dabigatran; Dru | 2013 |
A comparison of results of the US food and drug administration's mini-sentinel program with randomized clinical trials: the case of gastrointestinal tract bleeding with dabigatran.
Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Databases, Pharmaceutical; | 2014 |
[Gastrointestinal bleeding under treatment with new oral anticoagulants].
Topics: Administration, Oral; Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacemen | 2014 |
28 other studies available for beta-alanine and Gastrointestinal Hemorrhage
| Article | Year |
|---|---|
[Dabigatran as cause of severe gastrointestinal bleeding in a Jehovah's Witness patient].
Topics: Aged; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Transfusion; Critical | 2013 |
Dabigatran and postmarketing reports of bleeding.
Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Gastrointestinal Hemorrhage | 2013 |
Extracorporeal therapy for dabigatran removal in the treatment of acute bleeding: a single center experience.
Topics: Accidental Falls; Acute Disease; Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Benzim | 2013 |
[New oral anticoagulants and digestive hemorrhages].
Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Fe | 2014 |
Plasma dabigatran activity one week after discontinuation despite normal renal function.
Topics: Aged; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Gastroin | 2013 |
Anticoagulation-associated upper gastrointestinal haemorrhage.
Topics: Aged; Aged, 80 and over; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Female; Gastroint | 2013 |
Gastrointestinal bleeding associated with dabigatran in a patient with panhypopituitarism.
Topics: Aged; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Diagnosis, Differential; Embolism; Fe | 2014 |
Dabigatran-induced upper intestinal bleeding in a patient with chronic kidney disease.
Topics: Aged, 80 and over; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Diabetes Mellitus, | 2013 |
Multiple data sources, the best way to gather safety information about medications.
Topics: Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Gastrointestinal Hemorrhage; Humans; Produc | 2014 |
Ischemic stroke and intestinal bleeding under dabigatran in metabolic myopathy.
Topics: Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Brain Isc | 2013 |
Clinical experience of life-threatening dabigatran-related bleeding at a large, tertiary care, academic medical center: a case series.
Topics: Academic Medical Centers; Aged; Aged, 80 and over; Antithrombins; Benzimidazoles; beta-Alanine; Comb | 2014 |
Bleeding rates in Veterans Affairs patients with atrial fibrillation who switch from warfarin to dabigatran.
Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Al | 2014 |
Anticoagulant-related gastrointestinal bleeding--could this facilitate early detection of benign or malignant gastrointestinal lesions?
Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials, Phase III as Top | 2014 |
Risk of gastrointestinal bleeding with dabigatran: a head-to-head comparative study with rivaroxaban.
Topics: Aged; Aged, 80 and over; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Factor Xa Inhibito | 2014 |
Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation.
Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Benzimidazoles | 2015 |
Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation.
Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Benzimidazoles | 2015 |
Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation.
Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Benzimidazoles | 2015 |
Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation.
Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Benzimidazoles | 2015 |
The risks of thromboembolism vs. recurrent gastrointestinal bleeding after interruption of systemic anticoagulation in hospitalized inpatients with gastrointestinal bleeding: a prospective study.
Topics: Aged; Aged, 80 and over; Anticoagulants; Benzimidazoles; beta-Alanine; Cohort Studies; Dabigatran; E | 2015 |
Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study.
Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cohort S | 2015 |
Safety of new oral anticoagulants.
Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Gastrointestinal Hemorrha | 2015 |
Risk of gastrointestinal bleeding associated with oral anticoagulants: population based retrospective cohort study.
Topics: Administration, Oral; Adult; Age Factors; Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; | 2015 |
Prevention of Dabigatran-Related Gastrointestinal Bleeding With Gastroprotective Agents: A Population-Based Study.
Topics: Aged; Aged, 80 and over; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Female; Gastrointe | 2015 |
Anticoagulation therapy: Bleeding no worse with novel agents.
Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Gastrointestinal Hemorrha | 2015 |
Effective antidotes for new anticoagulants.
Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Gastrointestinal Hemorrha | 2015 |
Meta-analysis should not be subject to selectivity and imbalance.
Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Gastrointestinal Hemorrha | 2015 |
Neither dabigatran nor rivaroxaban were linked to increased GI bleeding compared with warfarin.
Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Female; Gastrointestinal Hemorrha | 2015 |
Dabigatran-induced gastrointestinal bleeding in an elderly patient with moderate renal impairment.
Topics: Acute Kidney Injury; Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Creati | 2012 |
Fatal gastrointestinal hemorrhage after a single dose of dabigatran.
Topics: Aged; Aged, 80 and over; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Fatal Outcome; Ga | 2012 |
Reversal of dabigatran-induced bleeding with a prothrombin complex concentrate and fresh frozen plasma.
Topics: Aged, 80 and over; Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation Factors; Dabigatra | 2012 |
Direct thrombin inhibitors: a case indicating benefit from 'plasmapheresis' in toxicity: a call for establishing "guidelines" in overdose and to find an "antidote"!
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antidotes; Antithrombins; Aspirin; Atrial Fibrillation; Ben | 2012 |